Share Price and Basic Stock Data
Last Updated: November 15, 2025, 3:07 pm
| PEG Ratio | 0.38 |
|---|
Analyst Insight & Comprehensive Analysis
Business Overview and Revenue Trends
Kuantum Papers Ltd operates in the Paper & Paper Products industry, with a current market capitalization of ₹946 Cr and a stock price of ₹108. The company reported sales of ₹1,310 Cr for the fiscal year ending March 2023, representing a significant increase from ₹830 Cr in March 2022. However, sales are projected to decline to ₹1,211 Cr in March 2024 and further to ₹1,107 Cr in March 2025, indicating potential headwinds in revenue generation. The quarterly sales figures for June 2023, September 2023, and December 2023 stood at ₹313 Cr, ₹298 Cr, and ₹301 Cr, respectively, showing a downward trend from the preceding fiscal year. This decline in sales is concerning, as it may reflect weakening demand or increased competition in the paper industry. The overall sales performance suggests that while the company has shown growth in the past, it now faces challenges that may impact its revenue trajectory moving forward.
Profitability and Efficiency Metrics
Kuantum Papers has demonstrated varying profitability metrics over recent quarters. The operating profit margin (OPM) stood at 18% for the current period, reflecting a decline from 35% in June 2023. The net profit for the year ending March 2023 was ₹136 Cr, which decreased to ₹115 Cr in March 2025. This drop in profitability is concerning, especially as the interest coverage ratio (ICR) is reported at 6.33x, indicating a reasonable ability to meet interest obligations. However, the decline in net profit margin to 10.40% in March 2025 from 15.17% in March 2024 raises questions about cost management and operational efficiency. Despite the challenges, the return on equity (ROE) remains relatively stable at 10.1%, indicating that the company is still capable of generating returns on shareholders’ equity, albeit under pressure from declining profits.
Balance Sheet Strength and Financial Ratios
The balance sheet of Kuantum Papers reveals a total debt of ₹654 Cr against reserves of ₹1,204 Cr, providing a debt-to-equity ratio of 0.53x, which is relatively low and indicates prudent financial management. The company’s borrowings decreased from ₹762 Cr in March 2022 to ₹654 Cr in March 2025, showcasing a positive trend in reducing leverage. The book value per share increased to ₹138.97 in March 2025, up from ₹128.79 in March 2024, indicating growth in shareholder equity. Additionally, the current ratio of 0.83x suggests potential liquidity challenges, as it falls below the typical benchmark of 1.0x. However, the quick ratio of 0.44x highlights the company’s reliance on inventory to meet short-term obligations, which could pose risks if market conditions shift. Overall, while the financial ratios indicate a solid foundation, the liquidity position warrants close monitoring.
Shareholding Pattern and Investor Confidence
Kuantum Papers maintains a stable shareholding structure, with promoters holding 70.31% of the equity, reflecting strong control and commitment from the founding members. The public shareholding stands at 29.68%, with the number of shareholders increasing from 11,678 in December 2022 to 22,729 in September 2025, indicating growing investor interest. However, foreign institutional investors (FIIs) have a negligible presence, with holdings fluctuating around 0.00% to 1.04% over the past quarters. This lack of foreign investment may suggest a cautious outlook from institutional investors regarding the company’s growth prospects. The absence of domestic institutional investors (DIIs) further emphasizes the need for Kuantum to enhance its appeal to a broader investment community. While the strong promoter holding is a positive aspect, the limited institutional participation could hinder the stock’s liquidity and overall market perception.
Outlook, Risks, and Final Insight
The outlook for Kuantum Papers appears mixed, with several strengths and risks to consider. On one hand, the company’s strong promoter backing and manageable debt levels position it well for stability amid market fluctuations. However, the declining sales and profitability metrics raise concerns about future performance. Additionally, the liquidity issues indicated by the current and quick ratios may impact the company’s operational flexibility. The primary risks include potential market volatility affecting demand for paper products and the increasing competitive landscape within the industry. If Kuantum can effectively navigate these challenges and implement strategies to enhance efficiency and profitability, it may stabilize its financial performance. Conversely, failure to address these issues may lead to further declines in shareholder value, necessitating a cautious approach by investors.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Kuantum Papers Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Mohit Paper Mills Ltd | 48.0 Cr. | 34.2 | 46.0/25.4 | 7.50 | 39.0 | 0.00 % | 12.0 % | 13.6 % | 10.0 |
| Gratex Industries Ltd | 6.07 Cr. | 20.0 | 28.4/14.2 | 55.2 | 12.2 | 0.00 % | 3.85 % | 2.52 % | 10.0 |
| Ganga Papers India Ltd | 90.1 Cr. | 83.6 | 118/75.1 | 58.5 | 28.4 | 0.00 % | 6.44 % | 5.19 % | 10.0 |
| Encode Packaging India Ltd | 3.91 Cr. | 12.4 | 19.0/10.8 | 10.3 | 0.00 % | 2.06 % | 2.12 % | 10.0 | |
| Cella Space Ltd | 28.0 Cr. | 13.9 | 19.3/9.11 | 29.1 | 10.3 | 0.00 % | 10.7 % | % | 10.0 |
| Industry Average | 810.18 Cr | 81.55 | 44.08 | 107.46 | 0.69% | 9.32% | 134.80% | 6.50 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 274 | 341 | 351 | 344 | 313 | 298 | 301 | 299 | 281 | 279 | 270 | 277 | 223 |
| Expenses | 213 | 242 | 246 | 230 | 203 | 218 | 222 | 235 | 209 | 218 | 220 | 217 | 183 |
| Operating Profit | 61 | 99 | 105 | 114 | 109 | 81 | 79 | 64 | 72 | 61 | 50 | 60 | 40 |
| OPM % | 22% | 29% | 30% | 33% | 35% | 27% | 26% | 21% | 25% | 22% | 19% | 22% | 18% |
| Other Income | -62 | 1 | 1 | 0 | 1 | 1 | 1 | 3 | 1 | 2 | 2 | 1 | 1 |
| Interest | 18 | 20 | 18 | 16 | 11 | 12 | 11 | 8 | 9 | 9 | 10 | 10 | 10 |
| Depreciation | 11 | 11 | 11 | 12 | 12 | 12 | 12 | 12 | 13 | 13 | 14 | 15 | 15 |
| Profit before tax | -31 | 69 | 77 | 87 | 87 | 57 | 56 | 46 | 51 | 40 | 28 | 36 | 16 |
| Tax % | 27% | 24% | 26% | 25% | 25% | 26% | 25% | 27% | 25% | 25% | 26% | 28% | 26% |
| Net Profit | -39 | 53 | 57 | 65 | 65 | 43 | 42 | 34 | 38 | 30 | 21 | 26 | 12 |
| EPS in Rs | -4.45 | 6.04 | 6.56 | 7.45 | 7.46 | 4.89 | 4.83 | 3.88 | 4.38 | 3.43 | 2.40 | 2.99 | 1.38 |
Last Updated: August 20, 2025, 7:55 am
Below is a detailed analysis of the quarterly data for Kuantum Papers Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 223.00 Cr.. The value appears to be declining and may need further review. It has decreased from 277.00 Cr. (Mar 2025) to 223.00 Cr., marking a decrease of 54.00 Cr..
- For Expenses, as of Jun 2025, the value is 183.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 217.00 Cr. (Mar 2025) to 183.00 Cr., marking a decrease of 34.00 Cr..
- For Operating Profit, as of Jun 2025, the value is 40.00 Cr.. The value appears to be declining and may need further review. It has decreased from 60.00 Cr. (Mar 2025) to 40.00 Cr., marking a decrease of 20.00 Cr..
- For OPM %, as of Jun 2025, the value is 18.00%. The value appears to be declining and may need further review. It has decreased from 22.00% (Mar 2025) to 18.00%, marking a decrease of 4.00%.
- For Other Income, as of Jun 2025, the value is 1.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 1.00 Cr..
- For Interest, as of Jun 2025, the value is 10.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 10.00 Cr..
- For Depreciation, as of Jun 2025, the value is 15.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 15.00 Cr..
- For Profit before tax, as of Jun 2025, the value is 16.00 Cr.. The value appears to be declining and may need further review. It has decreased from 36.00 Cr. (Mar 2025) to 16.00 Cr., marking a decrease of 20.00 Cr..
- For Tax %, as of Jun 2025, the value is 26.00%. The value appears to be improving (decreasing) as expected. It has decreased from 28.00% (Mar 2025) to 26.00%, marking a decrease of 2.00%.
- For Net Profit, as of Jun 2025, the value is 12.00 Cr.. The value appears to be declining and may need further review. It has decreased from 26.00 Cr. (Mar 2025) to 12.00 Cr., marking a decrease of 14.00 Cr..
- For EPS in Rs, as of Jun 2025, the value is 1.38. The value appears to be declining and may need further review. It has decreased from 2.99 (Mar 2025) to 1.38, marking a decrease of 1.61.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: November 15, 2025, 4:59 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 477 | 499 | 526 | 608 | 704 | 793 | 745 | 404 | 830 | 1,310 | 1,211 | 1,107 | 1,050 |
| Expenses | 402 | 435 | 460 | 490 | 556 | 637 | 625 | 374 | 710 | 930 | 860 | 860 | 865 |
| Operating Profit | 76 | 64 | 65 | 118 | 148 | 156 | 119 | 30 | 120 | 380 | 351 | 247 | 185 |
| OPM % | 16% | 13% | 12% | 19% | 21% | 20% | 16% | 7% | 14% | 29% | 29% | 22% | 18% |
| Other Income | 3 | 1 | 1 | 3 | 3 | 9 | 9 | 1 | 4 | -60 | -12 | 3 | 7 |
| Interest | 22 | 21 | 20 | 21 | 25 | 29 | 31 | 28 | 70 | 71 | 44 | 40 | 43 |
| Depreciation | 19 | 13 | 14 | 15 | 19 | 25 | 32 | 35 | 46 | 45 | 48 | 54 | 60 |
| Profit before tax | 37 | 32 | 33 | 84 | 107 | 111 | 65 | -32 | 8 | 203 | 248 | 155 | 89 |
| Tax % | 10% | 21% | 25% | 30% | 32% | 30% | -10% | -60% | -74% | 33% | 26% | 26% | |
| Net Profit | 34 | 25 | 25 | 59 | 73 | 78 | 72 | -13 | 13 | 136 | 184 | 115 | 65 |
| EPS in Rs | 3.84 | 2.87 | 2.81 | 6.79 | 8.35 | 8.93 | 8.23 | -1.46 | 1.54 | 15.60 | 21.07 | 13.20 | 7.43 |
| Dividend Payout % | 0% | 3% | 4% | 3% | 3% | 6% | 3% | 0% | 0% | 19% | 14% | 23% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -26.47% | 0.00% | 136.00% | 23.73% | 6.85% | -7.69% | -118.06% | 200.00% | 946.15% | 35.29% | -37.50% |
| Change in YoY Net Profit Growth (%) | 0.00% | 26.47% | 136.00% | -112.27% | -16.88% | -14.54% | -110.36% | 318.06% | 746.15% | -910.86% | -72.79% |
Kuantum Papers Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 8% |
| 5 Years: | 8% |
| 3 Years: | 10% |
| TTM: | -11% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 17% |
| 5 Years: | 10% |
| 3 Years: | 105% |
| TTM: | -43% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 30% |
| 5 Years: | 17% |
| 3 Years: | -1% |
| 1 Year: | -24% |
| Return on Equity | |
|---|---|
| 10 Years: | 10% |
| 5 Years: | 11% |
| 3 Years: | 16% |
| Last Year: | 10% |
Last Updated: September 5, 2025, 9:25 am
Balance Sheet
Last Updated: November 9, 2025, 2:23 pm
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 9 | 9 | 9 | 9 | 9 | 9 | 9 | 9 | 9 | 9 | 9 | 9 | 9 |
| Reserves | 100 | 532 | 552 | 612 | 683 | 758 | 823 | 809 | 822 | 958 | 1,115 | 1,204 | 1,196 |
| Borrowings | 177 | 224 | 243 | 302 | 321 | 395 | 573 | 689 | 762 | 513 | 512 | 654 | 678 |
| Other Liabilities | 94 | 91 | 100 | 88 | 109 | 123 | 144 | 108 | 83 | 210 | 251 | 246 | 276 |
| Total Liabilities | 379 | 856 | 903 | 1,011 | 1,121 | 1,284 | 1,549 | 1,614 | 1,676 | 1,689 | 1,888 | 2,113 | 2,158 |
| Fixed Assets | 265 | 673 | 687 | 772 | 825 | 978 | 1,034 | 1,436 | 1,408 | 1,414 | 1,475 | 1,619 | 1,741 |
| CWIP | 0 | 26 | 50 | 42 | 84 | 55 | 310 | 21 | 29 | 31 | 42 | 156 | 150 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 114 | 157 | 166 | 198 | 213 | 251 | 206 | 158 | 239 | 245 | 371 | 338 | 266 |
| Total Assets | 379 | 856 | 903 | 1,011 | 1,121 | 1,284 | 1,549 | 1,614 | 1,676 | 1,689 | 1,888 | 2,113 | 2,158 |
Below is a detailed analysis of the balance sheet data for Kuantum Papers Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 9.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 9.00 Cr..
- For Reserves, as of Sep 2025, the value is 1,196.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,204.00 Cr. (Mar 2025) to 1,196.00 Cr., marking a decrease of 8.00 Cr..
- For Borrowings, as of Sep 2025, the value is 678.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 654.00 Cr. (Mar 2025) to 678.00 Cr., marking an increase of 24.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 276.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 246.00 Cr. (Mar 2025) to 276.00 Cr., marking an increase of 30.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 2,158.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 2,113.00 Cr. (Mar 2025) to 2,158.00 Cr., marking an increase of 45.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 1,741.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,619.00 Cr. (Mar 2025) to 1,741.00 Cr., marking an increase of 122.00 Cr..
- For CWIP, as of Sep 2025, the value is 150.00 Cr.. The value appears to be declining and may need further review. It has decreased from 156.00 Cr. (Mar 2025) to 150.00 Cr., marking a decrease of 6.00 Cr..
- For Investments, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Other Assets, as of Sep 2025, the value is 266.00 Cr.. The value appears to be declining and may need further review. It has decreased from 338.00 Cr. (Mar 2025) to 266.00 Cr., marking a decrease of 72.00 Cr..
- For Total Assets, as of Sep 2025, the value is 2,158.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,113.00 Cr. (Mar 2025) to 2,158.00 Cr., marking an increase of 45.00 Cr..
Notably, the Reserves (1,196.00 Cr.) exceed the Borrowings (678.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -101.00 | -160.00 | -178.00 | -184.00 | -173.00 | -239.00 | -454.00 | -659.00 | -642.00 | -133.00 | -161.00 | -407.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 27 | 32 | 25 | 21 | 17 | 15 | 7 | 30 | 27 | 8 | 10 | 13 |
| Inventory Days | 105 | 107 | 102 | 117 | 133 | 95 | 141 | 145 | 114 | 88 | 126 | 141 |
| Days Payable | 89 | 54 | 47 | 47 | 54 | 47 | 42 | 124 | 47 | 25 | 64 | 47 |
| Cash Conversion Cycle | 43 | 85 | 80 | 91 | 95 | 63 | 105 | 51 | 94 | 71 | 73 | 107 |
| Working Capital Days | -33 | -4 | -4 | -6 | -0 | -5 | -19 | -17 | 10 | -4 | -22 | -25 |
| ROCE % | 21% | 10% | 7% | 12% | 14% | 13% | 8% | 0% | 5% | 22% | 20% | 11% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Basic EPS (Rs.) | 13.20 | 21.07 | 15.60 | 1.54 | -1.46 |
| Diluted EPS (Rs.) | 13.20 | 21.07 | 15.60 | 1.54 | -1.46 |
| Cash EPS (Rs.) | 19.39 | 26.59 | 20.81 | 6.83 | 2.53 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 138.97 | 128.79 | 110.79 | 95.17 | 93.65 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 138.97 | 128.79 | 110.79 | 95.17 | 93.65 |
| Dividend / Share (Rs.) | 3.00 | 3.00 | 0.00 | 0.00 | 0.00 |
| Revenue From Operations / Share (Rs.) | 126.86 | 138.81 | 150.07 | 95.16 | 46.28 |
| PBDIT / Share (Rs.) | 28.50 | 38.81 | 43.87 | 14.07 | 4.51 |
| PBIT / Share (Rs.) | 22.31 | 33.28 | 38.66 | 8.78 | 0.51 |
| PBT / Share (Rs.) | 17.81 | 28.37 | 23.26 | 0.88 | -3.65 |
| Net Profit / Share (Rs.) | 13.20 | 21.07 | 15.60 | 1.54 | -1.46 |
| PBDIT Margin (%) | 22.46 | 27.96 | 29.23 | 14.78 | 9.73 |
| PBIT Margin (%) | 17.58 | 23.97 | 25.76 | 9.23 | 1.11 |
| PBT Margin (%) | 14.03 | 20.44 | 15.49 | 0.92 | -7.88 |
| Net Profit Margin (%) | 10.40 | 15.17 | 10.39 | 1.61 | -3.15 |
| Return on Networth / Equity (%) | 9.49 | 16.35 | 14.08 | 1.61 | -1.55 |
| Return on Capital Employeed (%) | 10.90 | 18.31 | 22.78 | 5.10 | 0.30 |
| Return On Assets (%) | 5.45 | 9.73 | 8.05 | 0.80 | -0.78 |
| Long Term Debt / Equity (X) | 0.33 | 0.27 | 0.34 | 0.74 | 0.71 |
| Total Debt / Equity (X) | 0.53 | 0.45 | 0.49 | 0.88 | 0.78 |
| Asset Turnover Ratio (%) | 0.55 | 0.67 | 0.77 | 0.50 | 0.25 |
| Current Ratio (X) | 0.83 | 1.02 | 1.02 | 1.23 | 0.98 |
| Quick Ratio (X) | 0.44 | 0.64 | 0.58 | 0.73 | 0.63 |
| Inventory Turnover Ratio (X) | 9.26 | 3.55 | 4.50 | 4.31 | 1.90 |
| Dividend Payout Ratio (NP) (%) | 22.72 | 14.24 | 0.00 | 0.00 | 0.00 |
| Dividend Payout Ratio (CP) (%) | 15.47 | 11.28 | 0.00 | 0.00 | 0.00 |
| Earning Retention Ratio (%) | 77.28 | 85.76 | 0.00 | 0.00 | 0.00 |
| Cash Earning Retention Ratio (%) | 84.53 | 88.72 | 0.00 | 0.00 | 0.00 |
| Interest Coverage Ratio (X) | 6.33 | 7.90 | 5.39 | 1.78 | 1.42 |
| Interest Coverage Ratio (Post Tax) (X) | 3.93 | 5.29 | 3.81 | 1.19 | 0.85 |
| Enterprise Value (Cr.) | 1512.26 | 1786.29 | 1555.37 | 1448.18 | 1240.79 |
| EV / Net Operating Revenue (X) | 1.37 | 1.47 | 1.19 | 1.74 | 3.07 |
| EV / EBITDA (X) | 6.08 | 5.27 | 4.06 | 11.79 | 31.55 |
| MarketCap / Net Operating Revenue (X) | 0.79 | 1.12 | 0.80 | 0.84 | 1.44 |
| Retention Ratios (%) | 77.27 | 85.75 | 0.00 | 0.00 | 0.00 |
| Price / BV (X) | 0.72 | 1.20 | 1.10 | 0.84 | 0.71 |
| Price / Net Operating Revenue (X) | 0.79 | 1.12 | 0.80 | 0.84 | 1.44 |
| EarningsYield | 0.13 | 0.13 | 0.12 | 0.01 | -0.02 |
After reviewing the key financial ratios for Kuantum Papers Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 1.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 1.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 13.20. This value is within the healthy range. It has decreased from 21.07 (Mar 24) to 13.20, marking a decrease of 7.87.
- For Diluted EPS (Rs.), as of Mar 25, the value is 13.20. This value is within the healthy range. It has decreased from 21.07 (Mar 24) to 13.20, marking a decrease of 7.87.
- For Cash EPS (Rs.), as of Mar 25, the value is 19.39. This value is within the healthy range. It has decreased from 26.59 (Mar 24) to 19.39, marking a decrease of 7.20.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 138.97. It has increased from 128.79 (Mar 24) to 138.97, marking an increase of 10.18.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 138.97. It has increased from 128.79 (Mar 24) to 138.97, marking an increase of 10.18.
- For Dividend / Share (Rs.), as of Mar 25, the value is 3.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 3.00.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 126.86. It has decreased from 138.81 (Mar 24) to 126.86, marking a decrease of 11.95.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 28.50. This value is within the healthy range. It has decreased from 38.81 (Mar 24) to 28.50, marking a decrease of 10.31.
- For PBIT / Share (Rs.), as of Mar 25, the value is 22.31. This value is within the healthy range. It has decreased from 33.28 (Mar 24) to 22.31, marking a decrease of 10.97.
- For PBT / Share (Rs.), as of Mar 25, the value is 17.81. This value is within the healthy range. It has decreased from 28.37 (Mar 24) to 17.81, marking a decrease of 10.56.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 13.20. This value is within the healthy range. It has decreased from 21.07 (Mar 24) to 13.20, marking a decrease of 7.87.
- For PBDIT Margin (%), as of Mar 25, the value is 22.46. This value is within the healthy range. It has decreased from 27.96 (Mar 24) to 22.46, marking a decrease of 5.50.
- For PBIT Margin (%), as of Mar 25, the value is 17.58. This value is within the healthy range. It has decreased from 23.97 (Mar 24) to 17.58, marking a decrease of 6.39.
- For PBT Margin (%), as of Mar 25, the value is 14.03. This value is within the healthy range. It has decreased from 20.44 (Mar 24) to 14.03, marking a decrease of 6.41.
- For Net Profit Margin (%), as of Mar 25, the value is 10.40. This value exceeds the healthy maximum of 10. It has decreased from 15.17 (Mar 24) to 10.40, marking a decrease of 4.77.
- For Return on Networth / Equity (%), as of Mar 25, the value is 9.49. This value is below the healthy minimum of 15. It has decreased from 16.35 (Mar 24) to 9.49, marking a decrease of 6.86.
- For Return on Capital Employeed (%), as of Mar 25, the value is 10.90. This value is within the healthy range. It has decreased from 18.31 (Mar 24) to 10.90, marking a decrease of 7.41.
- For Return On Assets (%), as of Mar 25, the value is 5.45. This value is within the healthy range. It has decreased from 9.73 (Mar 24) to 5.45, marking a decrease of 4.28.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.33. This value is within the healthy range. It has increased from 0.27 (Mar 24) to 0.33, marking an increase of 0.06.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.53. This value is within the healthy range. It has increased from 0.45 (Mar 24) to 0.53, marking an increase of 0.08.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.55. It has decreased from 0.67 (Mar 24) to 0.55, marking a decrease of 0.12.
- For Current Ratio (X), as of Mar 25, the value is 0.83. This value is below the healthy minimum of 1.5. It has decreased from 1.02 (Mar 24) to 0.83, marking a decrease of 0.19.
- For Quick Ratio (X), as of Mar 25, the value is 0.44. This value is below the healthy minimum of 1. It has decreased from 0.64 (Mar 24) to 0.44, marking a decrease of 0.20.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 9.26. This value exceeds the healthy maximum of 8. It has increased from 3.55 (Mar 24) to 9.26, marking an increase of 5.71.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 22.72. This value is within the healthy range. It has increased from 14.24 (Mar 24) to 22.72, marking an increase of 8.48.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 15.47. This value is below the healthy minimum of 20. It has increased from 11.28 (Mar 24) to 15.47, marking an increase of 4.19.
- For Earning Retention Ratio (%), as of Mar 25, the value is 77.28. This value exceeds the healthy maximum of 70. It has decreased from 85.76 (Mar 24) to 77.28, marking a decrease of 8.48.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 84.53. This value exceeds the healthy maximum of 70. It has decreased from 88.72 (Mar 24) to 84.53, marking a decrease of 4.19.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 6.33. This value is within the healthy range. It has decreased from 7.90 (Mar 24) to 6.33, marking a decrease of 1.57.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 3.93. This value is within the healthy range. It has decreased from 5.29 (Mar 24) to 3.93, marking a decrease of 1.36.
- For Enterprise Value (Cr.), as of Mar 25, the value is 1,512.26. It has decreased from 1,786.29 (Mar 24) to 1,512.26, marking a decrease of 274.03.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.37. This value is within the healthy range. It has decreased from 1.47 (Mar 24) to 1.37, marking a decrease of 0.10.
- For EV / EBITDA (X), as of Mar 25, the value is 6.08. This value is within the healthy range. It has increased from 5.27 (Mar 24) to 6.08, marking an increase of 0.81.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.79. This value is below the healthy minimum of 1. It has decreased from 1.12 (Mar 24) to 0.79, marking a decrease of 0.33.
- For Retention Ratios (%), as of Mar 25, the value is 77.27. This value exceeds the healthy maximum of 70. It has decreased from 85.75 (Mar 24) to 77.27, marking a decrease of 8.48.
- For Price / BV (X), as of Mar 25, the value is 0.72. This value is below the healthy minimum of 1. It has decreased from 1.20 (Mar 24) to 0.72, marking a decrease of 0.48.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.79. This value is below the healthy minimum of 1. It has decreased from 1.12 (Mar 24) to 0.79, marking a decrease of 0.33.
- For EarningsYield, as of Mar 25, the value is 0.13. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded 0.13.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Kuantum Papers Ltd:
- Net Profit Margin: 10.4%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 10.9% (Industry Average ROCE: 9.32%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 9.49% (Industry Average ROE: 134.8%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 3.93
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.44
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 13.9 (Industry average Stock P/E: 44.08)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.53
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 10.4%
Fundamental Analysis of Kuantum Papers Ltd
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Paper & Paper Products | Paper Mill, Distt Hoshiarpur, Sailakhurd Punjab 144529 | kuantumcorp@kuantumpapers.com http://www.kuantumpapers.com |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Jagesh Kumar Khaitan | Chairman |
| Mr. Pavan Khaitan | Vice Chairman & Mng.Director |
| Mr. Bhavdeep Sardana | Independent Director |
| Mr. Vivek Bihani | Independent Director |
| Mr. Shireen Sethi | Independent Director |
| Mr. Drishinder Singh Sandhawalia | Non Exe.Non Ind.Director |
Kuantum Papers Ltd. Share Price Update | |
|---|---|
| Share Price | Value |
| Today | ₹159.45 |
| Previous Day | ₹155.15 |
FAQ
What is the intrinsic value of Kuantum Papers Ltd?
Kuantum Papers Ltd's intrinsic value (as of 15 November 2025) is 159.50 which is 54.85% higher the current market price of 103.00, indicating undervalued. Calculated using the PE ratio method, this valuation considers the company's 901 Cr. market cap, FY2025-2026 high/low of 148/95.2, reserves of ₹1,196 Cr, and liabilities of 2,158 Cr.
What is the Market Cap of Kuantum Papers Ltd?
The Market Cap of Kuantum Papers Ltd is 901 Cr..
What is the current Stock Price of Kuantum Papers Ltd as on 15 November 2025?
The current stock price of Kuantum Papers Ltd as on 15 November 2025 is 103.
What is the High / Low of Kuantum Papers Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Kuantum Papers Ltd stocks is 148/95.2.
What is the Stock P/E of Kuantum Papers Ltd?
The Stock P/E of Kuantum Papers Ltd is 13.9.
What is the Book Value of Kuantum Papers Ltd?
The Book Value of Kuantum Papers Ltd is 138.
What is the Dividend Yield of Kuantum Papers Ltd?
The Dividend Yield of Kuantum Papers Ltd is 2.91 %.
What is the ROCE of Kuantum Papers Ltd?
The ROCE of Kuantum Papers Ltd is 11.4 %.
What is the ROE of Kuantum Papers Ltd?
The ROE of Kuantum Papers Ltd is 10.1 %.
What is the Face Value of Kuantum Papers Ltd?
The Face Value of Kuantum Papers Ltd is 1.00.